Answer
Pneumonia is a recognised common adverse effect in people with COPD. Fever, chills, changed mucus, worsening cough or increased breathing difficulty should be assessed promptly.
Sources for this answer
- Trelegy Ellipta 92 micrograms/55 micrograms/22 micrograms inhalation powder, pre-dispensed — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.